Pharmaids Pharmaceuticals Limited (BOM:524572)
30.09
-0.12 (-0.40%)
At close: Sep 10, 2026
Pharmaids Pharmaceuticals Revenue
Pharmaids Pharmaceuticals had revenue of 41.21M INR in the quarter ending June 30, 2026, a decrease of -38.15%. This brings the company's revenue in the last twelve months to 253.40M, up 18.52% year-over-year. In the fiscal year ending March 31, 2026, Pharmaids Pharmaceuticals had annual revenue of 278.82M with 43.37% growth.
Revenue (ttm)
253.40M
Revenue Growth
+18.52%
P/S Ratio
4.22
Revenue / Employee
2.00M
Employees
127
Market Cap
1.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 278.82M | 84.35M | 43.37% |
| Mar 31, 2025 | 194.47M | 43.35M | 28.69% |
| Mar 31, 2024 | 151.12M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 39.39M | -46.12M | -53.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |
| Amwill Health Care | 454.92M |
Pharmaids Pharmaceuticals News
- 4 weeks ago - Pharmaids Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 3 months ago - Pharmaids Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 3 months ago - Pharmaids Pharmaceuticals Annual report: Q4 2026 - Filings
- 7 months ago - Pharmaids Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 10 months ago - Pharmaids Pharmaceuticals Quarterly report: Q2 2026 - Filings